NOTCH3 and malignant colon neoplasm: In summary, these findings suggest that elevated NOTCH3 expression correlates with poor survival outcomes in colon cancer and is associated with altered immune cell infiltration and immune checkpoint expression, highlighting its potential as a prognostic marker and therapeutic target.